PNC Financial Services Group
DSGN icon

PNC Financial Services Group’s Design Therapeutics DSGN Stock Holding History

PNC Financial Services Group’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Hold
1,816
– – ﹤0.01% 3663
2026
Q1 		$19.3K Hold
1,816
– – ﹤0.01% 3702
2025
Q4 		$17K Sell
1,816
-7
-0.4% -$55 ﹤0.01% 3736
2025
Q3 		$13.7K Buy
1,823
+152
+9% +$761 ﹤0.01% 3801
2025
Q2 		$5.63K Sell
1,671
-7,580
-82% -$28.4K ﹤0.01% 4087
2025
Q1 		$35.7K Buy
9,251
+32
+0.3% +$153 ﹤0.01% 3272
2024
Q4 		$56.9K Hold
9,219
– – ﹤0.01% 3031
2024
Q3 		$49.6K Sell
9,219
-473
-5% -$2.23K ﹤0.01% 3096
2024
Q2 		$32.5K Sell
9,692
-1,151
-11% -$4.49K ﹤0.01% 3252
2024
Q1 		$43.7K Buy
10,843
+9,370
+636% +$25K ﹤0.01% 3053
2023
Q4 		$3.9K Buy
+1,473
New +$3.37K ﹤0.01% 4011

Other funds holding DSGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
OC
Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM

PNC Financial Services Group's DSGN Position: Q2 2026 in Review

PNC Financial Services Group held its Design Therapeutics (DSGN) position steady in Q2 2026 at 1,816 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #3663.

PNC Financial Services Group first reported a position in DSGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $56.9K in Q4 2024. 37 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • PNC Financial Services Group held 1,816 shares of Design Therapeutics worth $26.3K as of Q2 2026.
  • PNC Financial Services Group left its Design Therapeutics share count unchanged in Q2 2026.
  • Design Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3663 holding.
  • PNC Financial Services Group first reported a position in Design Therapeutics in Q4 2023 and has held it in 11 quarters since.
  • PNC Financial Services Group's Design Therapeutics position peaked at $56.9K in Q4 2024.
  • 37 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.